Bone Marrow Involvement by Hodgkin and Non-Hodgkin Lymphomas

Hematology/Oncology Clinics of North America

Volumn 23, Issue 4, 2009, Pages 873-902

  Zhang, Qian Yun ^a   Foucar, Kathryn ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow lymphoma; Hodgkin; Immunophenotype; Molecular genetic assessment of non Hodgkin lymphomas; Non Hodgkin lymphomas

Indexed keywords

CYCLIN D1; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 2; T LYMPHOCYTE RECEPTOR;

AGGRESSIVE NK CELL LEUKEMIA; B CELL LYMPHOMA; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER MORPHOLOGY; CANCER RELAPSE; CANCER STAGING; DIAGNOSTIC VALUE; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GENOTYPE; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; LYMPHATIC LEUKEMIA; LYMPHOBLASTOMA; LYMPHOCYTOMA; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MYCOSIS FUNGOIDES; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REED STERNBERG CELL; REVIEW; SEZARY SYNDROME;

BONE MARROW; BONE MARROW EXAMINATION; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, NON-HODGKIN; PROGNOSIS; REED-STERNBERG CELLS;

EID: 67649418448     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.04.014     Document Type: Review

References (73)

1. Cheson B.D. Staging and evaluation of the patient with lymphoma. Hematol Oncol Clin North Am 22 5 (2008) 825-837 vii-viii
2. Kwee T.C., Kwee R.M., Verdonck L.F., et al. Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma. Br J Haematol 141 1 (2008) 60-68
3. Hasserjian R.P. Reactive versus neoplastic bone marrow: problems and pitfalls. Arch Pathol Lab Med 132 4 (2008) 587-594
4. Viswanatha D. Procurement and interpretation of the bone marrow specimen. In: King D., Gardner W., Sobin L., et al. (Eds). Non-neoplastic disorders of bone marrow (AFIP fascicle) (2008), American Registry of Pathology, Washington, DC 41-55
5. Viswanatha D., and Foucar K. Hodgkin and non-Hodgkin lymphoma involving bone marrow. Semin Diagn Pathol 20 3 (2003) 196-210
6. Rawstron A.C., Bennett F.L., O'Connor S.J., et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 359 6 (2008) 575-583
7. Perea G., Altes A., Bellido M., et al. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL). Histopathology 45 3 (2004) 268-274
8. Foucar K. Non-Hodgkin lymphoma and Hodgkin lymphoma (disease) in bone marrow. Bone marrow pathology. 2nd edition (2001), ASCP Press, Chicago (IL) 438-483
9. Arber D.A., and George T.I. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol 29 12 (2005) 1549-1557
10. Costes V., Duchayne E., Talb J., et al. Intrasinusoidal bone marrow infiltration: a common growth pattern for different lymphoma subtypes. Br J Haematol 119 4 (2002) 916-922
11. Howell S.J., Grey M., Chang J., et al. The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol 119 2 (2002) 408-411
12. Simpson C.D., Gao J., Fernandez C.V., et al. Routine bone marrow examination in the initial evaluation of paediatric Hodgkin lymphoma: the Canadian perspective. Br J Haematol 141 6 (2008) 820-826
13. Vassilakopoulos T.P., Angelopoulou M.K., Constantinou N., et al. Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma. Blood 105 5 (2005) 1875-1880
14. Stein H., Delsol G., Pileri S.A., et al. Classical Hodgkin lymphoma. In: Swerdlow S., Campo E., and Harris N. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 326-329
15. Khoury J.D., Jones D., Yared M.A., et al. Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 28 4 (2004) 489-495
16. Poppema S., Delsol G., Pileri S.A., et al. Nodular lymphocyte predominant Hodgkin lymphoma. In: Jaffe E., Harris N., Stein H., et al. (Eds). WHO classification of tumours: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 323-325
17. Weiss L.M., von Wasielewski R., Delsol G., et al. In: Jaffe E., Harris N., Stein H., et al. (Eds). WHO classification of tumours: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 331
18. Joshi A., and Aqel N.M. Hodgkin's disease of bone marrow masquerading as a heavy plasma cell infiltration and fibrosis. Br J Haematol 122 3 (2003) 343
19. Taylor C.R., and Levenson R.M. Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment II. Histopathology 49 4 (2006) 411-424
20. Walker R.A. Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment I. Histopathology 49 4 (2006) 406-410
21. Bernharroch D., Stein H., and Peh S.-C. Lymphocyte-depleted classical Hodgkin lymphoma. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 334
22. Ponzoni M., Fumagalli L., Rossi G., et al. Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Mod Pathol 15 12 (2002) 1273-1278
23. Canioni D., Brice P., Lepage E., et al. Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the Groupe d'Etude des Lymphomes Folliculaires. Br J Haematol 126 3 (2004) 364-371
24. Schmidt B., Kremer M., Gotze K., et al. Bone marrow involvement in follicular lymphoma: comparison of histology and flow cytometry as staging procedures. Leuk Lymphoma 47 9 (2006) 1857-1862
25. Abramson J.S. T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management. Oncologist 11 4 (2006) 384-392
26. Rodriguez J., Pugh W.C., and Cabanillas F. T-cell-rich B-cell lymphoma. Blood 82 5 (1993) 1586-1589
27. Chung R., Lai R., Wei P., et al. Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index. Blood 110 4 (2007) 1278-1282
28. Talaulikar D., Dahlstrom J.E., Shadbolt B., et al. Role of immunohistochemistry in staging diffuse large B-cell lymphoma (DLBCL). J Histochem Cytochem 56 10 (2008) 893-900
29. Braziel R., Arber D., Slovak M., et al. The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood 97 12 (2001) 3713-3720
30. Harris N.L., Swerdlow S.H., Jaffe E.S., et al. Follicular lymphoma. In: Swerdlow S., Campo E., and Harris N. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues. 4th edition (2008), IARC Press, Lyon, France 220-226
31. Isaacson P., Piris M., Berger F., et al. Splenic marginal zone lymphoma. In: Swerdlow S., Campo E., and Harris N. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 185-187
32. Borowitz M., and Chan J. Precursor lymphoid neoplasms. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 167-178
33. Foucar K. Reactive lymphoid proliferations in blood and bone marrow. In: Foucar K. (Ed). Bone marrow pathology. 2nd edition (2001), ASCP Press, Chicago 344-363
34. McKenna R.W., Washington L.T., Aquino D.B., et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood 98 8 (2001) 2498-2507
35. Rimsza L., Larson R., Winter S., et al. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol (2000) 11466-11475
36. Anon. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89 11 (1997) 3909-3918
37. Müller-Hermelink H.K., Montserrat E., Catovsky D., et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 180-182
38. Bernard M., Gressin R., Lefrere F., et al. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Leukemia 15 11 (2001) 1785-1791
39. Swerdlow S., Campo E., Seto M., et al. Mantle cell lymphoma. In: Swerdlow S., Campo E., and Harris N. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 229-232
40. Gu K., Chan W.C., and Hawley R.C. Practical detection of t(14;18)(IgH/BCL2) in follicular lymphoma. Arch Pathol Lab Med 132 8 (2008) 1355-1361
41. Vitolo U., Ferreri A.J., and Montoto S. Lymphoplasmacytic lymphoma - Waldenstrom's macroglobulinemia. Crit Rev Oncol Hematol 67 2 (2008) 172-185
42. Dimopoulos M.A., Merlini G., Leblond V., et al. How we treat Waldenstrom's macroglobulinemia. Haematologica 90 1 (2005) 117-125
43. Zucca E., Bertoni F., Stathis A., et al. Marginal zone lymphomas. Hematol Oncol Clin North Am 22 5 (2008) 883-901 viii
44. Takeshita M., Sakai H., Okamura S., et al. Splenic large B-cell lymphoma in patients with hepatitis C virus infection. Hum Pathol 36 8 (2005) 878-885
45. Hunt K.E., and Reichard K.K. Diffuse large B-cell lymphoma. Arch Pathol Lab Med 132 1 (2008) 118-124
46. Lenz G., Wright G.W., Emre N.C., et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A 105 36 (2008) 13520-13525
47. Kremer M., Spitzer M., Mandl-Weber S., et al. Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogenous group of disorders. Lab Invest 83 1 (2003) 107-114
48. Gascoyne R.D. Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 11 5 (1997) 847-862
49. Lossos I.S., and Morgensztern D. Prognostic biomarkers in diffuse large B-cell lymphoma. J Clin Oncol 24 6 (2006) 995-1007
50. Shipp M.A., Ross K.N., Tamayo P., et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8 1 (2002) 68-74
51. De Wolf-Peeters C., Delabie J., Campo E., et al. T cell/histiocyte-rich large B-cell lymphoma. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 238-239
52. Lim M., Beaty M., Sorbara L., et al. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol 26 11 (2002) 1458-1466
53. Leonchini L., Raphael M., Stein H., et al. Burkitt lymphoma. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissue (2008), IARC Press, Lyon, France 262-263
54. Kelly G.L., and Rickinson A.B. Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy. Hematology Am Soc Hematol Educ Program 2007 (2007) 277-284
55. Swerdlow S., Campo E., Harris N., et al. WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France
56. Dogan A., and Morice W.G. Bone marrow histopathology in peripheral T-cell lymphomas. Br J Haematol 127 2 (2004) 140-154
57. Delsol G., Falini B., Muller-Hermelink H., et al. Anaplastic large cell lymphoma (ALCL), ALK-positive. In: Swerdlow S., Campo E., and Harris N. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 312-316
58. Mussolin L., Pillon M., d'Amore E.S., et al. Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma. Leukemia 19 9 (2005) 1643-1647
59. Onciu M., Behm F.G., Raimondi S.C., et al. ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature. Am J Clin Pathol 120 4 (2003) 617-625
60. Vega F., Medeiros L.J., Bueso-Ramos C., et al. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol 116 3 (2001) 410-419
61. Gaulard P., Jaffe E., Krenacs L., et al. Hepatosplenic T-cell lymphoma. In: Swerdlow S., Campo E., and Harris N. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 292-293
62. Chan J., Jaffe E., Ralfkiaer E., et al. Aggressive NK-cell leukaemia. In: Jaffe E., Harris N., and Stein H. (Eds). WHO classification of tumours: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 276-277
63. Allory Y., Challine D., Haioun C., et al. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. Am J Surg Pathol 25 7 (2001) 865-874
64. Grogg K.L., Morice W.G., and Macon W.R. Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma. Br J Haematol 137 5 (2007) 416-422
65. Good D.J., and Gascoyne R.D. Classification of non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 22 5 (2008) 781-805 vii
66. Ralfkiaer E., Cerroni L., Sander C.A., et al. Mycosis fungoides. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissue (2008), IARC Press, Lyon, France 296-298
67. Ralfkiaer E., Willemze R., and Whittaker S.J. Sézary syndrome. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classification of tumours: pathology & genetics: tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 299
68. van Doorn R., van Kester M.S., Dijkman R., et al. Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood 113 1 (2009) 127-136
69. Morice W.G., Katzmann J.A., Pittelkow M.R., et al. A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sezary syndrome. Am J Clin Pathol 125 3 (2006) 364-374
70. Vonderheid E.C. On the diagnosis of erythrodermic cutaneous T-cell lymphoma. J Cutan Pathol 33 Suppl (2006) 127-142
71. Muzzafar T., Wei E.X., Lin P., et al. Flow cytometric immunophenotyping of anaplastic large cell lymphoma. Arch Pathol Lab Med 133 1 (2009) 49-56
72. Chan J.K., Lamant L., Algar E., et al. ALK+ histiocytes: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood 112 7 (2008) 2965-2968
73. Foucar K, Osuji N, Matutes E, et al. T-cell large granular lymphocytic leukemia, indolent NK lymphocytosis and aggressive NK cell leukemia. In Armitage J, Coiffer B, Dalla-Favera R, et al, editors. Non-Hodgkin lymphoma, 2nd edition. Baltimore (MD): Lippincott Williams & Wilkins; 2009, in press.